Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of …
A Sepriano, A Kerschbaumer, SA Bergstra… - Annals of the …, 2023 - ard.bmj.com
Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic
(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to inform the 2022 …
(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to inform the 2022 …
[HTML][HTML] Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis
HK Min, SH Kim, HR Kim, SH Lee - International Journal of Molecular …, 2022 - mdpi.com
Targeting specific pathologic pro-inflammatory cytokines or related molecules leads to
excellent therapeutic effects in inflammatory arthritis, including rheumatoid arthritis …
excellent therapeutic effects in inflammatory arthritis, including rheumatoid arthritis …
Incidence of severe infection in patients with rheumatoid arthritis taking biologic agents: a systematic review
K Makimoto, R Konno, A Kinoshita… - JBI Evidence …, 2023 - journals.lww.com
Objective: The objective of this review was to estimate the population-based incidence and
determine the types of severe infection and deaths experienced by patients with rheumatoid …
determine the types of severe infection and deaths experienced by patients with rheumatoid …
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis
R Sen, M Riofrio, JA Singh - Expert Opinion on Drug Safety, 2024 - Taylor & Francis
Introduction Disease-modifying anti-rheumatic drugs (DMARDs) have improved the
outcomes of patients with rheumatoid arthritis (RA). DMARDs are classified into three …
outcomes of patients with rheumatoid arthritis (RA). DMARDs are classified into three …
[HTML][HTML] Risk of severe infection among rheumatoid arthritis patients on biological dmards: A population-based cohort study
M Bellan, L Scotti, D Ferrante, E Calzaducca… - Journal of Clinical …, 2022 - mdpi.com
Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the
management of rheumatoid arthritis, although their benefits are counterweight by an …
management of rheumatoid arthritis, although their benefits are counterweight by an …
[PDF][PDF] Biological treatment and exercise as an alternative to typical rheumatoid arthritis therapy: pathophysiology and effects Leczenie biologiczne i ćwiczenia fizyczne …
WSSS Kardynała, E Białowąs - 2023 - apcz.umk.pl
Wstęp: Reumatoidalne zapalenie stawów (RZS) jest przewlekłą chorobą
autoimmunologiczną o nieznanej etiologii, która dotyczy głównie stawów, ale mogą też …
autoimmunologiczną o nieznanej etiologii, która dotyczy głównie stawów, ale mogą też …
Biological treatment and exercise as an alternative to typical rheumatoid arthritis therapy: pathophysiology and effects
A Aghadi, K Brzuszkiewicz, E Dybała, I Cuber… - Journal of Education …, 2023 - apcz.umk.pl
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease of unknown
etiology that mainly affects the joints, but extra-articular symptoms may also occur. The …
etiology that mainly affects the joints, but extra-articular symptoms may also occur. The …